PAL Technologies is an award winning company providing clinical tools for the patient-centred measurement of free-living, everyday activities and behaviour, providing researchers and clinicians with robust evidence for treatment interventions and disease related risks. Based on more than 25 years of R&D across a range of patient groups, PAL’s miniaturised single sensor platform technology also benefits from recent developments in advanced Micro-Electro-Mechanical Systems (MEMS). Since its spin-out from the Bioengineering Unit at the University of Strathclyde in 2001 by co-founders Douglas Maxwell, Professor Malcolm Granat and Dr Nikos Mourselas, PAL Technologies has been providing support from its Glasgow headquarters to more than 200 institutions worldwide. Many of these researchers, spread across almost 50 countries, are investigating the correlation between physical behaviours and chronic disease. By working in close partnership with its customers to deliver clinically relevant measures to support and inform patient-centred treatment approaches, PAL Technologies is proud to be helping to build healthier lives. For more information see the Product Page of this LinkedIn profile, telephone us on +44 141 303 8380 or email us at info@paltechnologies.com. ** Follow us on LinkedIn ** ** Find us on twitter (www.twitter.com/paltechnologies) ** ** Like us on Facebook (https://www.facebook.com/PALtechnologies) **